跳至主要内容
临床试验/ACTRN12616001213437
ACTRN12616001213437已完成3 期

Ondansetron to reduce vomiting in children receiving intranasal fentanyl and inhaled nitrous oxide for procedural sedation: a double blind, randomised placebo controlled trial

Murdoch Children’s Research Institute0 个研究点目标入组 442 人开始时间: 2016年9月1日最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
442

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
3 Years 至 18 Years(—)
性别
All

入选标准

  • 1. Be aged from 3 years to 18 years
  • 2. Weight equal or greater than 15 kg
  • 3. Planned procedural sedation with the combination of intranasal fentanyl and nitrous oxide
  • 4. Have written informed consent provided by a parent or legal guardian. The participant may
  • also provide consent if he/she is deemed competent.

排除标准

  • 1. Contraindication to receiving intranasal fentanyl: opioid allergy and acute/chronic nasal
  • 2. Contraindication to receiving nitrous oxide as per institutional sedation manual
  • 3. Contraindication to receiving ondansetron or placebo: known arrhythmia, use of QT-
  • prolonging drugs or allergy to any component of the ondansetron or placebo syrups
  • 4. Cardiorespiratory instability
  • 5. Decreased level of consciousness
  • 6. Concomitant head injury
  • 7. Planned use of additional sedatives

研究者

发起方
Murdoch Children’s Research Institute

相似试验